Hypothyroidism is a systemic endocrine condition in which the thyroid gland produces insufficient thyroxine (T4) and triiodothyronine (T3) to meet the body’s metabolic demands, leading to a generalized slowing of metabolic processes. It is the physiological and clinical opposite of hyperthyroidism, in which the thyroid produces excess hormone. The underlying mechanism most often involves autoimmune destruction of thyroid follicular cells (as in Hashimoto’s thyroiditis), iodine deficiency impairing hormone synthesis, surgical or radioactive-iodine ablation of thyroid tissue, or pituitary/hypothalamic failure to stimulate the gland (central hypothyroidism). It can be transient and mild, as in postpartum thyroiditis, or permanent and severe, as in untreated myxedema coma. Clinically relevant subtypes include primary acquired hypothyroidism (E03.9), congenital hypothyroidism (E03.0, E03.1), iodine-deficiency hypothyroidism (E02), and postprocedural/iatrogenic hypothyroidism (E89.0). It is most often confused with subclinical hypothyroidism, which reflects an isolated elevated TSH with a normal free T4 and does not always require treatment, and with myxedema, which refers specifically to the severe, decompensated form marked by non-pitting skin and soft-tissue edema rather than the disease process itself.
The word entered English in the early 1900s as hypothyroidism (noun), built directly in English from the earlier anatomical term thyroid (1690s), which itself was coined in Latin as glandula thyreoidea by analogy to the Greek adjective describing the gland’s shield-like shape. The root thyreos (“shield”) connects hypothyroidism to the entire -thyroid root family: thyroiditis (inflammation of the shield-shaped gland), thyrotoxicosis (poisoning by excess thyroid hormone), and thyroidectomy (surgical removal of the gland). The prefix hypo- is highly productive in medical terminology, also appearing in hypoglycemia, hypotension, hypoxia, and hyperthyroidism (its direct antonym).
🔀 ALIASES / ALTERNATE TERMS
Underactive thyroid(lay term; most common patient-facing synonym for hypothyroidism)
Myxedema(clinical synonym for severe, longstanding hypothyroidism with characteristic non-pitting skin/soft-tissue changes; the life-threatening decompensated form is separately coded as myxedema coma, E03.5)
Subclinical hypothyroidism(partial/lesser biochemical form — isolated TSH elevation with normal free T4; coded E02 when due to iodine deficiency, otherwise typically captured under E03.9)
Congenital hypothyroidism(etiologic subtype present from birth; E03.0 with goiter, E03.1 without goiter)
Postprocedural hypothyroidism(etiologic subtype following thyroidectomy or radioactive iodine ablation; E89.0)
Drug-induced hypothyroidism(etiologic subtype caused by medicaments or exogenous substances such as lithium or amiodarone; E03.2)
Postinfectious hypothyroidism(etiologic subtype following an infectious thyroiditis; E03.3)
Atrophic thyroiditis(anatomic/pathologic subtype with acquired thyroid gland atrophy, often the “burned-out” end stage of autoimmune thyroiditis; E03.4)
Iodine-deficiency hypothyroidism(etiologic subtype from inadequate dietary iodine; congenital forms E00.0-E00.9, subclinical form E02)
🔗 RELATED TERMS
hyperthyroidism — the opposite of hypothyroidism; excess production of thyroid hormone causing a hypermetabolic state rather than a hypometabolic one
Hashimoto’s thyroiditis — the most common cause of primary hypothyroidism in iodine-sufficient regions; autoimmune lymphocytic destruction of thyroid tissue, coded E06.3
myxedema — severe, decompensated form of hypothyroidism; when it progresses to a life-threatening metabolic crisis it is coded as myxedema coma, E03.5
goiter — thyroid gland enlargement that may accompany hypothyroidism, distinguishing E03.0 (with goiter) from E03.1 (without goiter)
thyroid-stimulating hormone (TSH) — pituitary hormone whose elevation is the primary biochemical marker used to diagnose and monitor hypothyroidism
levothyroxine — synthetic T4 hormone that is the standard lifelong replacement therapy for hypothyroidism
thyroiditis — inflammation of the thyroid gland; a common underlying cause of both transient and permanent hypothyroidism
⚠️ Coding Note: Sequencing depends on etiology: code the underlying cause first when it is documented and separately classifiable (e.g., sequence E03.3 after the causative thyroiditis, or use E03.2 with an additional T-code identifying the causative drug per the poisoning/adverse-effect guidelines). For postprocedural hypothyroidism, E89.0 should be sequenced according to the guideline for postprocedural conditions — code first any documented complication of the procedure, then E89.0 to identify the hypothyroidism itself. A frequently undercoded entity is E03.4 (atrophy of thyroid, acquired); documentation phrases such as “burned-out Hashimoto’s,” “small/atrophic thyroid on ultrasound,” or “end-stage autoimmunethyroiditis” should trigger a coder query to confirm this more specific code rather than defaulting to unspecified E03.9. Payers commonly require a documented, trending TSH (and sometimes free T4) to support ongoing levothyroxine therapy and prior authorization for brand-name formulations, and LCDs for thyroid testing (e.g., limiting simultaneous first-line TSH and free T4 ordering) should be checked against the ordering diagnosis before billing 84443 and 84439 together.